| Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels P Bonadonna, O Perbellini, G Passalacqua, B Caruso, S Colarossi, ... Journal of allergy and clinical immunology 123 (3), 680-686, 2009 | 428 | 2009 |
| Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ... Blood, The Journal of the American Society of Hematology 126 (16), 1921-1924, 2015 | 266 | 2015 |
| Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases S Raponi, M Stefania De Propris, S Intoppa, M Laura Milani, A Vitale, ... Leukemia & lymphoma 52 (6), 1098-1107, 2011 | 243 | 2011 |
| Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells M Ricciardi, M Zanotto, G Malpeli, G Bassi, O Perbellini, M Chilosi, F Bifari, ... British journal of cancer 112 (6), 1067-1075, 2015 | 180 | 2015 |
| Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow–derived mesenchymal stromal cells AH Nwabo Kamdje, F Mosna, F Bifari, V Lisi, G Bassi, G Malpeli, ... Blood, The Journal of the American Society of Hematology 118 (2), 380-389, 2011 | 147 | 2011 |
| Neutrophil activation and survival are modulated by interaction with NK cells C Costantini, A Micheletti, F Calzetti, O Perbellini, G Pizzolo, ... International immunology 22 (10), 827-838, 2010 | 146 | 2010 |
| Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM I Álvarez-Twose, R Zanotti, D González-de-Olano, P Bonadonna, A Vega, ... Journal of allergy and clinical immunology 133 (2), 520-528. e5, 2014 | 140 | 2014 |
| Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFNγ: role of CD18, ICAM-1, and ICAM-3 C Costantini, F Calzetti, O Perbellini, A Micheletti, C Scarponi, S Lonardi, ... Blood, The Journal of the American Society of Hematology 117 (5), 1677-1686, 2011 | 131 | 2011 |
| Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction C Dalla Pellegrina, O Perbellini, MT Scupoli, C Tomelleri, C Zanetti, ... Toxicology and applied pharmacology 237 (2), 146-153, 2009 | 131 | 2009 |
| Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels R Zanotti, C Lombardo, G Passalacqua, C Caimmi, M Bonifacio, ... Journal of Allergy and Clinical Immunology 136 (1), 135-139, 2015 | 116 | 2015 |
| How much specific is the association between hymenoptera venom allergy and mastocytosis? P Bonadonna, R Zanotti, M Pagani, B Caruso, O Perbellini, S Colarossi, ... Allergy 64 (9), 1379-1382, 2009 | 105 | 2009 |
| Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia PT Kamga, G Bassi, A Cassaro, M Midolo, M Di Trapani, A Gatti, ... Oncotarget 7 (16), 21713, 2016 | 97 | 2016 |
| Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients O Marini, C Spina, E Mimiola, A Cassaro, G Malerba, G Todeschini, ... Oncotarget 7 (19), 27676, 2016 | 95 | 2016 |
| CD 30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis JM Morgado, O Perbellini, RC Johnson, C Teodósio, A Matito, ... Histopathology 63 (6), 780-787, 2013 | 95 | 2013 |
| Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy P Bonadonna, R Zanotti, B Caruso, L Castellani, O Perbellini, S Colarossi, ... Journal of Allergy and Clinical Immunology 121 (1), 256-257, 2008 | 87 | 2008 |
| Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial A Vitale, A Guarini, C Ariola, G Meloni, O Perbellini, M Pizzuti, ... Haematologica 92 (3), 342-348, 2007 | 87 | 2007 |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia F Diop, R Moia, C Favini, E Spaccarotella, L De Paoli, A Bruscaggin, ... haematologica 105 (2), 448, 2020 | 84 | 2020 |
| Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 … MT Scupoli, M Donadelli, F Cioffi, M Rossi, O Perbellini, G Malpeli, ... Haematologica 93 (4), 524-532, 2008 | 81 | 2008 |
| Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients A Giardino, G Innamorati, S Ugel, O Perbellini, R Girelli, I Frigerio, P Regi, ... Pancreatology 17 (6), 962-966, 2017 | 70 | 2017 |
| Outcome prediction by immunophenotypic minimal residual disease detection in adult T‐cell acute lymphoblastic leukaemia M Krampera, A Vitale, C Vincenzi, O Perbellini, A Guarini, L Annino, ... British journal of haematology 120 (1), 74-79, 2003 | 70 | 2003 |
Alberto ZamòUniversity of Würzburg在 uni-wuerzburg.de 的电子邮件经过验证
